Cardiometabolic Consequences of Targeted Anticancer Therapies. Guha A, Gong Y, DeRemer D, Owusu-Guha J, et al. J Cardiovasc Pharmacol 2022;80:515-521.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guha A, Gong Y, DeRemer D, Owusu-Guha J, et al. Cardiometabolic Consequences of Targeted Anticancer Therapies. J Cardiovasc Pharmacol 2022;80:515-521.
PMID: 34654781